US EditionAnti-Abortion Stigma Could Be Holding Breast Cancer Research Back
Summary by Bioethics.com
3 Articles
3 Articles
An editorial by 'The Lancet' denounces that prejudices towards mifepristone, a compound used for voluntary termination of pregnancy, have limited its research as a preventive drug, despite its potential benefit in women with BRCA mutations Read
·Madrid, Spain
Read Full Article
Abortion drug could help reduce risk of breast cancer, group of medics says
(The Guardian) – A drug used in medical abortions could help prevent women at high risk of breast cancer from developing the disease, according to an international group of doctors and scientists. However, “stigma” around mifepristone is stopping pharmaceutical companies from investigating its potential as a new treatment doctors could offer to reduce the risk of breast cancer, they say. (Read More)
Coverage Details
Total News Sources3
Leaning Left0Leaning Right1Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium
